Free Trial
NYSE:PRGO

Perrigo (PRGO) Stock Price, News & Analysis

Perrigo logo
$22.04 -0.52 (-2.28%)
Closing price 03:59 PM Eastern
Extended Trading
$22.14 +0.10 (+0.45%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Perrigo Stock (NYSE:PRGO)

Key Stats

Today's Range
$21.78
$22.91
50-Day Range
$22.04
$28.41
52-Week Range
$21.03
$30.93
Volume
2.39 million shs
Average Volume
1.65 million shs
Market Capitalization
$3.03 billion
P/E Ratio
N/A
Dividend Yield
5.26%
Price Target
$33.00
Consensus Rating
Hold

Company Overview

Perrigo Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
92nd Percentile Overall Score

PRGO MarketRank™: 

Perrigo scored higher than 92% of companies evaluated by MarketBeat, and ranked 156th out of 1,853 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Perrigo has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Perrigo has only been the subject of 2 research reports in the past 90 days.

  • Read more about Perrigo's stock forecast and price target.
  • Earnings Growth

    Earnings for Perrigo are expected to grow by 19.53% in the coming year, from $2.56 to $3.06 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Perrigo is -37.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Perrigo is -37.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Perrigo has a P/B Ratio of 0.70. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    4.61% of the outstanding shares of Perrigo have been sold short.
  • Short Interest Ratio / Days to Cover

    Perrigo has a short interest ratio ("days to cover") of 5.5.
  • Change versus previous month

    Short interest in Perrigo has recently increased by 26.29%, indicating that investor sentiment is decreasing significantly.
  • Dividend Leadership

    Perrigo is a leading dividend payer. It pays a dividend yield of 5.14%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Perrigo has been increasing its dividend for 23 years.

  • Dividend Sustainability

    Based on earnings estimates, Perrigo will have a dividend payout ratio of 37.91% next year. This indicates that Perrigo will be able to sustain or increase its dividend.

  • Read more about Perrigo's dividend.
  • Percentage of Shares Shorted

    4.61% of the outstanding shares of Perrigo have been sold short.
  • Short Interest Ratio / Days to Cover

    Perrigo has a short interest ratio ("days to cover") of 5.5.
  • Change versus previous month

    Short interest in Perrigo has recently increased by 26.29%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Perrigo has a news sentiment score of -0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 21 news articles for Perrigo this week, compared to 7 articles on an average week.
  • Search Interest

    Only 2 people have searched for PRGO on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added Perrigo to their MarketBeat watchlist in the last 30 days. This is a decrease of -60% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Perrigo insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.40% of the stock of Perrigo is held by insiders.

  • Percentage Held by Institutions

    95.91% of the stock of Perrigo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Perrigo's insider trading history.
Receive PRGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Perrigo and its competitors with MarketBeat's FREE daily newsletter.

PRGO Stock News Headlines

HIDDEN IN THE BOOK OF GENESIS…
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.
Perrigo (NYSE:PRGO) Reaches New 1-Year Low Following Weak Earnings
See More Headlines

PRGO Stock Analysis - Frequently Asked Questions

Perrigo's stock was trading at $25.71 at the beginning of 2025. Since then, PRGO stock has decreased by 14.3% and is now trading at $22.0350.

Perrigo Company plc (NYSE:PRGO) released its quarterly earnings data on Wednesday, August, 6th. The company reported $0.57 earnings per share for the quarter, missing the consensus estimate of $0.59 by $0.02. The business's revenue was down .9% compared to the same quarter last year.
Read the conference call transcript
.

The following companies are subsidiaries of Perrigo: HRA Pharma, Ranir, Laboratoire de la Mer SAS, Geiss Destin & Dunn, ScarAway, Omega Pharma, Elan Corporation, and others.

Perrigo's top institutional shareholders include Cooke & Bieler LP (2.40%), Sound Shore Management Inc CT (2.39%), Geode Capital Management LLC (1.79%) and Copeland Capital Management LLC (1.64%). Insiders that own company stock include Svend Andersen, Ronald Craig Janish, Geoffrey M Parker, James E Dillard III, Robert Willis, Patrick Lockwood-Taylor, Alison Ives, Grainne Quinn, Eduardo Guarita Bezerra, Katherine C Doyle, Jeffrey B Kindler, Thomas Farrington and Murray S Kessler.
View institutional ownership trends
.

Shares of PRGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Perrigo investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Advanced Micro Devices (AMD), ServiceNow (NOW) and Arista Networks (ANET).

Company Calendar

Record date for 6/17 Dividend
5/30/2025
Ex-Dividend for 6/17 Dividend
5/30/2025
Dividend Payable
6/17/2025
Last Earnings
8/06/2025
Today
8/11/2025
Record date for 9/16 Dividend
8/29/2025
Ex-Dividend for 9/16 Dividend
8/29/2025
Dividend Payable
9/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceuticals
Current Symbol
NYSE:PRGO
CIK
1585364
Employees
8,379
Year Founded
1887

Price Target and Rating

High Price Target
$40.00
Low Price Target
$27.00
Potential Upside/Downside
+50.6%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.58)
Trailing P/E Ratio
N/A
Forward P/E Ratio
8.56
P/E Growth
N/A
Net Income
-$171.80 million
Net Margins
-1.86%
Pretax Margin
2.39%
Return on Equity
9.09%
Return on Assets
3.96%

Debt

Debt-to-Equity Ratio
0.81
Current Ratio
2.32
Quick Ratio
1.24

Sales & Book Value

Annual Sales
$4.37 billion
Price / Sales
0.69
Cash Flow
$4.90 per share
Price / Cash Flow
4.47
Book Value
$31.66 per share
Price / Book
0.69

Miscellaneous

Outstanding Shares
137,580,000
Free Float
137,033,000
Market Cap
$3.02 billion
Optionable
Optionable
Beta
0.47

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NYSE:PRGO) was last updated on 8/11/2025 by MarketBeat.com Staff
From Our Partners